Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), has led to a pandemic since March 2020. The …

The novel coronavirus disease 2019 (COVID‐19) emerged in late December 2019 in china
and has rapidly spread to many countries around the world. The effective pharmacotherapy …

SARS-COV-2 virus is responsible for the ongoing devastating pandemic. Since the early
phase of the pandemic, the “cytokine-storm” appeared a peculiar aspect of SARS-COV-2 …

There is an urgent need for ultrarapid testing regimens to detect the severe acute respiratory
syndrome coronavirus 2 [SARS-CoV-2] infections in real-time within seconds to stop its …

Abstract The coronavirus disease 2019 (COVID-19) is a highly transmissible disease
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that poses a …

Abstract The coronavirus disease 2019 (COVID-19) may cause not only an acute respiratory
distress syndrome (ARDS) but also multiple organ damage and failure requiring intensive …

Kidney transplantation recipients (KTR) with coronavirus disease 2019 (COVID-19) are at
higher risk of death than general population. However, mortality risk factors in KTR are still …

Abstract The World Health Organization (WHO) declared COVID-19 as a pandemic on
March 11, 2020, because of its widespread transmission and infection rates. The unique …

Background COVID-19 is associated with acute respiratory distress and cytokine release
syndrome. The Janus kinase (JAK) 1/JAK2 inhibitor ruxolitinib reduces inflammatory …

ABSTRACT Introduction Neutralizing antibodies (NAbs) that target key domains of the spike
protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may have …